Details
Category: Volume 07 Issue 07 July 2019
Hits: 996

Title: The Relationship between Antimicrobial Stewardship and Patient Outcomes: Health Care Costs, Mortality, Complications and HCAI

Authors: Dr Ambuj Shandil, Dr Jayshree Murlidharan, Dr Arun Bansal, Dr Karthi N, Dr Arnav Shandil

 DOI: https://dx.doi.org/10.18535/jmscr/v7i7.126

Abstract

Background and Objectives: Inappropriate antimicrobial use has rapidly become a global concern leading to increased antimicrobial resistance. Antibiotic resistant organisms are not only becoming increasingly difficult to treat but also lead to increased treatment costs, longer duration of hospital stay and in some cases even death; over 30% of deaths have been attributed to antimicrobial resistance (AMR). In setting of ICU, AMR has been shown to be associated with increased ICU mortality, complications and cost of treatment which can be a huge burden for emerging economies. We therefore decided to conduct this before and after study to test the feasibility of a clinical protocol based ASP with respect to pattern of HCAI, acquisition of resistance and mortality.

Methods:  This study was a prospective before and after study design which was divided into 3 phases over a span of 12 months. A pre- implementation audit (phase 1) was conducted for 1st 3 months studying various prescription practices that were being followed in ICU and general observation. Antimicrobial stewardship was implemented in phase 2 for a period of 6 months. After the implementation of ASP in PICU, a similar audit on antimicrobial prescription and usage was done in next three months (phase 3) and the results compared with the audit of pre-implementation period.

Results: Our study was designed to note effect of antimicrobial stewardship on HCAI outcomes, cost, complications and mortality patterns in Pediatric ICU. Our findings revealed that there was a statistically significant reduction in health care associated infections (HCAI) from 24.2% in pre implementation (phase1) to 3.2% following implementation of ASP with statistically significant p value of 0.001, similar difference in cost of antimicrobials was also noted in both phases. Adverse drug reaction needing to stop the drug were 7% in phase 1 which statistically reduced to 1% following implementation of ASP. However we were not able to find any statistically significant change in mortality pattern between pre and post ASP implementation phases.

Keywords: antimicrobial stewardship (AMS), antimicrobial resistance (AMR) , multi drug resistant (MDR), health care associated infections (HCAI).

References

  1. Vandijck DM, Depaemelaere M, Labeau SO, Depuydt PO, Annemans L, Buyle FM, et al. Daily cost of antimicrobial therapy in patients with Intensive Care Unit-acquired, laboratory-confirmed bloodstream infection. Int J Antimicrob Agents. 2008 Feb;31(2):161–5.
  2. Newland JG, Hersh AL. Purpose and design of antimicrobial stewardship programs in pediatrics. Pediatr Infect Dis J. 2010 Sep;29(9):862–3.
  3. Leekha S, Terrell CL, Edson RS. General principles of antimicrobial therapy. Mayo Clin Proc. 2011 Feb;86(2):156–67.
  4. WHO Guidelines on Hand Hygiene in Health Care: First Global Patient Safety Challenge Clean Care Is Safer Care [Internet]. Geneva: World Health Organization; 2009. (WHO Guidelines Approved by the Guidelines Review Committee). Available from: http://www.ncbi.nlm.nih.gov/books/NBK144013/
  5. Chou DTS, Achan P, Ramachandran M. The World Health Organization “5 moments of hand hygiene”: the scientific foundation. J Bone Joint Surg Br. 2012 Apr;94(4):441–5.
  6. Pittet D, Allegranzi B, Storr J, Donaldson L. “Clean Care is Safer Care”: the Global Patient Safety Challenge 2005-2006. Int J Infect Dis IJID Off Publ Int Soc Infect Dis. 2006 Nov;10(6):419–24.
  7. Vincent J-L. Nosocomial infections in adult intensive-care units. Lancet Lond Engl. 2003 Jun 14;361(9374):2068–77.
  8. Zaidi AKM, Huskins WC, Thaver D, Bhutta ZA, Abbas Z, Goldmann DA. Hospital-acquired neonatal infections in developing countries. Lancet Lond Engl. 2005 Apr 26;365(9465):1175–88.
  9. Rosenthal VD, Maki DG, Salomao R, Moreno CA, Mehta Y, Higuera F, et al. Device-associated nosocomial infections in 55 intensive care units of 8 developing countries. Ann Intern Med. 2006 Oct 17;145(8):582–91.
  10. Hanberger H, Garcia-Rodriguez JA, Gobernado M, Goossens H, Nilsson LE, Struelens MJ. Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries. French and Portuguese ICU Study Groups. JAMA. 1999 Jan 6;281(1):67–71.
  11. Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH, et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA. 1995 Aug 23;274(8):639–44.
  12. Blot S. Limiting the attributable mortality of nosocomial infection and multidrug resistance in intensive care units. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2008 Jan;14(1):5–13.
  13. Blot S, Depuydt P, Vandewoude K, De Bacquer D. Measuring the impact of multidrug resistance in nosocomial infection. Curr Opin Infect Dis. 2007 Aug;20(4):391–6.
  14. Agwu AL, Lee CKK, Jain SK, Murray KL, Topolski J, Miller RE, et al. A World Wide Web-based antimicrobial stewardship program improves efficiency, communication, and user satisfaction and reduces cost in a tertiary care pediatric medical center. Clin Infect Dis Off Publ Infect Dis Soc Am. 2008 Sep 15;47(6):747–53.
  15. Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest. 1999 Feb;115(2):462–74.
  16. Apisarnthanarak A, Holzmann-Pazgal G, Hamvas A, Olsen MA, Fraser VJ. Antimicrobial use and the influence of inadequate empiric antimicrobial therapy on the outcomes of nosocomial bloodstream infections in a neonatal intensive care unit. Infect Control Hosp Epidemiol. 2004 Sep;25(9):735–41.
  17. Timbrook TT, Hurst JM, Bosso JA. Impact of an Antimicrobial Stewardship Program on Antimicrobial Utilization, Bacterial Susceptibilities, and Financial Expenditures at an Academic Medical Center. Hosp Pharm. 2016 Oct;51(9):703–11.
  18. Jenkins TC, Knepper BC, Shihadeh K, Haas MK, Sabel AL, Steele AW, et al. Long-term outcomes of an antimicrobial stewardship program implemented in a hospital with low baseline antibiotic use. Infect Control Hosp Epidemiol. 2015 Jun;36(6):664–72.
  19. Kaki R, Elligsen M, Walker S, Simor A, Palmay L, Daneman N. Impact of antimicrobial stewardship in critical care: a systematic review. J Antimicrob Chemother. 2011 Jun;66(6):1223–30.
  20. Nowak MA, Nelson RE, Breidenbach JL, Thompson PA, Carson PJ. Clinical and economic outcomes of a prospective antimicrobial stewardship program. Am J Health-Syst Pharm AJHP Off J Am Soc Health-Syst Pharm. 2012 Sep 1;69(17):1500–8.
  21. Morris AC, Hay AW, Swann DG, Everingham K, McCulloch C, McNulty J, et al. Reducing ventilator-associated pneumonia in intensive care: impact of implementing a care bundle. Crit Care Med. 2011 Oct;39(10):2218–24.
  22. Taggart LR, Leung E, Muller MP, Matukas LM, Daneman N. Differential outcome of an antimicrobial stewardship audit and feedback program in two intensive care units: a controlled interrupted time series study. BMC Infect Dis [Internet]. 2015 Oct 29 [cited 2016 Dec 30];15. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4625716/
  23. Raymond DP, Pelletier SJ, Crabtree TD, Gleason TG, Hamm LL, Pruett TL, et al. Impact of a rotating empiric antibiotic schedule on infectious mortality in an intensive care unit. Crit Care Med. 2001 Jun;29(6):1101–8.

Corresponding Author

Dr Arnav Shandil, MD

Civil Hospital Theog, Shimla H.P, India